Improving Care for Inpatients with Diabetic Ketoacidosis
The Great Lakes Practice Transformation Network (GLPTN) is delighted to welcome Dr. Amisha Wallia, Assistant Professor of Medicine (Endocrinology) at Northwestern’s Feinberg School of Medicine, for an upcoming webinar titled “Improving Care for Inpatients with Diabetic Ketoacidosis.”
Diabetic Ketoacidosis (DKA) is an acute, life-threatening complication of uncontrolled diabetes. In the last decade, DKA hospitalizations have increased by 40% in the US, and it is common for patients with recurrent DKA to have extremely high rates of hospitalization. In this webinar, Dr. Wallia will focus on methods to improve the quality of care provided to DKA patients to improve their outcomes and reduce likelihood of recurrence. A brief Q&A session will follow Dr. Wallia’s presentation.
Target Audience: This webinar is designed for physicians and other healthcare professionals.
• Review diabetic ketoacidosis and need for improvement in care
• Review a quality improvement project to improve care for those in DKA
• Preventing recurrent DKA, reviewing next steps
About Dr. Wallia:
Dr. Amisha Wallia completed her medical degree at the Georgetown University School of Medicine, where she served as a student council and advocacy student member promoting for improvement in chronic care for those in need. She began her research career in diabetes while completing her Internal Medicine residency and subsequent fellowship in Endocrinology at Northwestern University Feinberg School of Medicine. At the same time, she completed a NIH T32 post-doctoral fellowship in Endocrinology, examining risks of hyperglycemia and diabetes in a high risk group (transplant recipients) on long term outcomes while also completing her Master of Science in Clinical Investigation through Northwestern’s School of Public Health. Now an Assistant Professor in the Division of Endocrinology, Metabolism and Molecular Medicine, and the Center for Healthcare Studies within the Institute of Public Health, Dr. Wallia has built a research group focused on improvement in the care of diabetes and its complications. Currently, she serves as co-investigator on several multi-center NIH trials and follow up studies including Diabetes Prevention Program Outcomes Study (DPPOS), the Diabetes Control and Complications Trial and Follow up study (DCCT/EDIC), and Preventing Early Renal Loss in Diabetes Study (PERL). Her clinical trials work early on evaluated the early effects of glycemic control with insulin, and subsequent effects in the transplant population; she has subsequently expanded to other high risk DM groups, including those diabetic ketoacidosis, renal insufficiency, and those with hypoglycemia. Dr. Wallia’s work transects the clinical, research, and quality arenas as it relates to both Type 1 and Type 2 Diabetes and its complications.